For students, homemakers, caregivers and daily commuters, the scheme promises tangible savings and greater freedom of movement.For students, homemakers, caregivers and daily commuters, the scheme promises tangible savings and greater freedom of movement.
India’s drug regulator has taken its most serious regulatory action against the major cancer centre’s Ethics Committee in Bengaluru, confirming lapses first reported by South First in June 2025.
The Singareni saga has many parallels with the Satyam scandal of almost 20 years ago.
